GROUP ONE TRADING, L.P. - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 45 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$15,376
-60.6%
43,932
-57.7%
0.00%
Q3 2022$39,000
-18.8%
103,935
-0.1%
0.00%
Q2 2022$48,000
-14.3%
104,035
-7.4%
0.00%
Q1 2022$56,000
+47.4%
112,397
+68.0%
0.00%
Q4 2021$38,000
-55.8%
66,897
-19.6%
0.00%
Q3 2021$86,000
+13.2%
83,239
+31.1%
0.00%
Q2 2021$76,000
-61.0%
63,512
-57.8%
0.00%
Q1 2021$195,000
+178.6%
150,374
+685.8%
0.00%
Q4 2020$70,000
+25.0%
19,136
-26.8%
0.00%
Q3 2020$56,000
+143.5%
26,125
+105.0%
0.00%
Q2 2020$23,000
+15.0%
12,745
-14.3%
0.00%
Q1 2020$20,000
-78.5%
14,876
-70.9%
0.00%
-100.0%
Q4 2019$93,000
-23.8%
51,076
+20.8%
0.00%0.0%
Q3 2019$122,000
+117.9%
42,282
+101.4%
0.00%0.0%
Q2 2019$56,000
+47.4%
20,998
+40.4%
0.00%
Q1 2019$38,000
+65.2%
14,956
+78.7%
0.00%
Q4 2018$23,000
+35.3%
8,367
+341.3%
0.00%
Q3 2018$17,0001,8960.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$206,0000.12%
Baker Brothers Advisors 4,608,786$16,914,0000.06%
Artal Group S.A. 500,000$1,835,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 90,000$331,0000.04%
Spotlight Asset Group, Inc. 21,500$79,0000.03%
DCF Advisers, LLC 18,755$69,0000.03%
683 Capital Management, LLC 88,470$325,0000.02%
Palo Alto Investors LP 77,044$283,0000.02%
Alpine Global Management, LLC 13,966$51,0000.01%
TCI Wealth Advisors, Inc. 4,000$15,0000.01%
View complete list of IDERA PHARMACEUTICALS INC shareholders